Menu
  • About RedHill
  • Products
  • Partnering
  • Investors
  • News
  • Contact
  • CAREERS
  • Press Releases

     
    Press Releases
      Date Summary View
    Nov 5, 2010
    PDF
    Oct 5, 2010
    PDF
    Sep 12, 2010
    Tel Aviv, September 12, 2010 – RedHill Biopharma Ltd, an Israeli biopharmaceutical company, has completed the first part of a private placement, raising $3.5 million dollars. The Company also reports the final closing of two transactions, a co-development agreement and an acquisition, both for late clinical-stage drugs. RedHill is also exp...
    PDF
    Aug 31, 2010
    Sydney, NSW, 31 August 2010 - Giaconda Limited (ASX:GIA) (the “Company”) today announced that it has completed the sale of its Myoconda, Heliconda and Picoconda patents to RedHill Biopharma Ltd (“RedHill”) as announced in the 16 August 2010 release.  Giaconda is receiving an upfront payment of US$500...
    PDF
    Aug 30, 2010
    SAINT LAURENT, QUEBEC–(Marketwire – Aug. 30, 2010) – IntelGenx Corp. (TSX VENTURE:IGX)(OTCBB:IGXT) (“IntelGenx”) and RedHill Biopharma Ltd., an Israeli corporation (“RedHill”) today announced that they have entered into a co-development and commercialization agreement for IntelGenx’...
    PDF
    May 6, 2010
    BOTHELL, WA, May 6, 2010, – SCOLR Pharma, Inc. (NYSE AMEX: DDD) today announced that it has executed a Licensing Agreement with RedHill Biopharma Ltd. an Israeli corporation, (RedHill), granting RedHill the worldwide rights to market and sell ondansetron tablet formulations based on SCOLR’s proprietary extended delivery technology (C...
    PDF
    Dec 2, 2009
    Copenhagen, Denmark – December 2nd 2009, Egalet a/s, Denmark and RedHill Biopharma Ltd. Israel, have entered into an exclusive license agreement that enables RedHill to further develop and commercialize Egalet’s proprietary program EG-P042. EG-P042 is Egalet’s prolonged release formulation of the active component Carvedilol. Th...
    PDF
    Page: FirstPrevious ...
    30

    Subscribe to press releases